Advances in umbilical cord transplantation: The role of thymoglobulin/ATG in cord blood transplantation

Best Practice and Research: Clinical Haematology

Volumn 23, Issue 2, 2010, Pages 275-282

  Mohty, Mohamad ^a,b   Gaugler, Beatrice ^c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

anti thymocyte globulin; engraftment; graft versus host disease; unrelated cord blood transplantation

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR1 ANTIGEN; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT VERSUS HOST DISEASE; ADHESION; B LYMPHOCYTE; BONE MARROW; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CHRONIC GRAFT VERSUS HOST DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DENDRITIC CELL; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENGRAFTMENT; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MYELOABLATIVE CONDITIONING; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REGULATORY T LYMPHOCYTE; REVIEW; T CELL DEPLETION; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 77956570203     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2010.05.004     Document Type: Review

References (41)

1. P. Ljungman, M. Bregni, and M. Brune Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 Bone Marrow Transplant 45 2010 219 234
2. V. Rocha, M. Labopin, and G. Sanz Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia N Engl J Med 351 2004 2276 2285
3. M.J. Laughlin, M. Eapen, and P. Rubinstein Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia N Engl J Med 351 2004 2265 2275
4. J.N. Barker, A. Scaradavou, and C.E. Stevens Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies Blood 115 2010 1843 1849
5. H. Narimatsu, S. Miyakoshi, and T. Yamaguchi Chronic graft-versus-host disease following umbilical cord blood transplantation: retrospective survey involving 1072 patients in Japan Blood 112 2008 2579 2582
6. M.L. MacMillan, D.J. Weisdorf, and C.G. Brunstein Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors Blood 113 2009 2410 2415
7. K.V. Komanduri, L.S. St John, and M. de Lima Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing Blood 110 2007 4543 4551
8. A.O. Gaber, A.P. Monaco, and J.A. Russell Rabbit antithymocyte globulin (thymoglobulin(r)): 25 years and new frontiers in solid organ transplantation and haematology Drugs 70 2010 691 732
9. A. Bacigalupo, T. Lamparelli, and P. Bruzzi Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO) Blood 98 2001 2942 2947
10. M. Mohty, J.O. Bay, and C. Faucher Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen Blood 102 2003 470 476 (Pubitemid 36841962)
11. A. Bacigalupo Antithymocyte globulin for prevention of graft-versus-host disease Curr Opin Hematol 12 2005 457 462
12. J. Kurtzberg, M. Laughlin, and M.L. Graham Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients N Engl J Med 335 1996 157 166
13. E. Gluckman, V. Rocha, and A. Boyer-Chammard Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group N Engl J Med 337 1997 373 381
14. P. Rubinstein, C. Carrier, and A. Scaradavou Outcomes among 562 recipients of placental-blood transplants from unrelated donors N Engl J Med 339 1998 1565 1577
15. P. Szabolcs, and D. Niedzwiecki Immune reconstitution after unrelated cord blood transplantation Cytotherapy 9 2007 111 122
16. M.J. Laughlin, J. Barker, and B. Bambach Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors N Engl J Med 344 2001 1815 1822
17. C.G. Brunstein, J.N. Barker, and D.J. Weisdorf Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease Blood 110 2007 3064 3070
18. V. Rocha, J. Cornish, and E.L. Sievers Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia Blood 97 2001 2962 2971
19. S. Takahashi, T. Iseki, and J. Ooi Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies Blood 104 2004 3813 3820
20. S. Takahashi, J. Ooi, and A. Tomonari Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen Blood 109 2007 1322 1330
21. M. Eapen, P. Rubinstein, and M.J. Zhang Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study Lancet 369 2007 1947 1954
22. M. Mohty Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond Leukemia 21 2007 1387 1394
23. I. Tsuge, and S. Kojima Comparison of antibody specificities of four anti-thymocyte/anti-lymphocyte globulin products Curr Therapeutic Res 56 1995 671 677
24. X. Preville, M. Flacher, and B. LeMauff Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model Transplantation 71 2001 460 468
25. N. Bonnefoy-Berard, and J.P. Revillard Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3 J Heart Lung Transplant 15 1996 435 442
26. M.C. Michallet, X. Preville, and M. Flacher Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins Transplantation 75 2003 657 662
27. D. Chappell, A. Beiras-Fernandez, and C. Hammer In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model Transplantation 81 2006 552 558
28. J.S. Bourdage, and D.M. Hamlin Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry Transplantation 59 1995 1194 1200
29. M.S. Zand, T. Vo, and J. Huggins Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways Transplantation 79 2005 1507 1515
30. P. Monti, P. Allavena, and V. Di Carlo Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells Int Immunopharmacol 3 2003 189 196
31. S. Gillet-Hladky, C.M. de Carvalho, and J. Bernaud Rabbit antithymocyte globulin inhibits monocyte-derived dendritic cells maturation in vitro and polarizes monocyte-derived dendritic cells towards tolerogenic dendritic cells expressing indoleamine 2,3-dioxygenase Transplantation 82 2006 965 974
32. M. Lopez, M.R. Clarkson, and M. Albin A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells J Am Soc Nephrol 17 2006 2844 2853
33. X. Feng, S. Kajigaya, and E.E. Solomou Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro Blood 111 2008 3675 3683
34. R. Lowsky, T. Takahashi, and Y.P. Liu Protective conditioning for acute graft-versus-host disease N Engl J Med 353 2005 1321 1331
35. H.E. Kohrt, B.B. Turnbull, and K. Heydari TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors Blood 114 2009 1099 1109
36. C.G. Brunstein, D.J. Weisdorf, and T. DeFor Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation Blood 108 2006 2874 2880
37. A.H. Blaes, Q. Cao, and J.E. Wagner Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation Biol Blood Marrow Transplant 16 2010 287 291
38. J. Sanz, M.A. Sanz, and S. Saavedra Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia Biol Blood Marrow Transplant 16 2010 86 94
39. E. Magro, C. Regidor, and R. Cabrera Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor Haematologica 91 2006 640 648
40. V.K. Prasad, A. Mendizabal, and S.H. Parikh Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes Blood 112 2008 2979 2989
41. A. Bacigalupo, T. Lamparelli, and G. Barisione Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation Biol Blood Marrow Transplant 12 2006 560 565